Back to Awarded Treatment Trials
Awarded Trial: 01T-411
Secondary Drug Intervention
Duration of Study Period for Each Subject
Eighty-six patients were enrolled and 73 completed the trial. Galantamine treatment did not differ from placebo on a composite score of cognitive measures but did show a benefit on verbal memory and the digit-symbol subtest.
Buchanan RW, Conley RR, Dickinson D, Ball MP, Feldman S, Gold JM, McMahon RP. Galantamine for the treatment of cognitive impairments in people with schizophrenia. Am J Psychiatry 2008;165:82-89.
Maryland Psychiatric Research Center
University of Maryland
P.O. Box 21247
City or Town
State or Province
Zip or Postal Code